Growth Metrics

National Research (NRC) Liabilities and Shareholders Equity (2016 - 2025)

National Research's Liabilities and Shareholders Equity history spans 16 years, with the latest figure at $134.9 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 1.76% year-over-year to $134.9 million; the TTM value through Dec 2025 reached $547.2 million, up 8.49%, while the annual FY2025 figure was $134.9 million, 1.76% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $134.9 million at National Research, down from $135.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $157.5 million in Q4 2021 and bottomed at $119.1 million in Q2 2024.
  • The 5-year median for Liabilities and Shareholders Equity is $134.9 million (2022), against an average of $136.5 million.
  • The largest annual shift saw Liabilities and Shareholders Equity soared 30.03% in 2021 before it dropped 17.19% in 2022.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $157.5 million in 2021, then decreased by 17.19% to $130.5 million in 2022, then fell by 6.15% to $122.4 million in 2023, then increased by 8.25% to $132.5 million in 2024, then increased by 1.76% to $134.9 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Liabilities and Shareholders Equity are $134.9 million (Q4 2025), $135.7 million (Q3 2025), and $141.4 million (Q2 2025).